- $669.68m
- $562.51m
- $360.58m
- 22
- 77
- 59
- 52
2019 December 31st | 2020 December 31st | 2021 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | fx Final | fx Final | fx Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 0 | 361 |
Cost of Revenue | ||||
Gross Profit | 0 | 0 | 0 | 146 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 3.75 | 3.64 | 5.67 | 279 |
Operating Profit | -3.75 | -3.64 | -5.67 | 81.5 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -3.75 | -6.12 | -16.8 | 81.2 |
Provision for Income Taxes | ||||
Net Income After Taxes | -3.75 | -6.12 | -16.8 | 83.2 |
Net Income Before Extraordinary Items | ||||
Net Income | -3.75 | -6.12 | -16.8 | 83.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -3.75 | -6.12 | -16.8 | 83.2 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.021 | -0.034 | -0.093 | 0.462 |
Dividends per Share |